Implementation of “Coverage With Evidence Development” Drug Approval Strategies Found Lacking
ISPOR—The Professional Society for Health Economics and Outcomes ResearchValue in Health announced new research from The Netherlands showing important gaps in the deployment of “coverage with evidence development,” a type of pharmaceutical managed entry agreement that gives patients access to treatments while additional evidence is being collected.